Home

MACENG_Fig1_ext.jpg

c20/20:

Advancing The Development and Commercialization of Ophthalmic Bioengineered Technologies and Drug Delivery

 

With $4M in funding through the Ontario Research Fund, a new innovation hub specializing in development and commercialization of materials and bioengineering in the ophthalmic space has been created. By providing matching funds for cash or in-kind collaborations, we are seeking industrial partnerships to leverage our skills and resources.